Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003220113 | SCV003908867 | uncertain significance | Inborn genetic diseases | 2023-02-27 | criteria provided, single submitter | clinical testing | The c.4366G>A (p.V1456I) alteration is located in exon 35 (coding exon 33) of the CC2D2A gene. This alteration results from a G to A substitution at nucleotide position 4366, causing the valine (V) at amino acid position 1456 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005036699 | SCV005664596 | uncertain significance | Meckel syndrome, type 6; Joubert syndrome 9; COACH syndrome 2; Retinitis pigmentosa 93 | 2024-02-22 | criteria provided, single submitter | clinical testing |